Pub. Date : 1997 Jul
PMID : 9254059
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Addition of tetrahydrolipstatin (THL, an LPL active-site inhibitor) to HTG-VLDL + LPL, inhibited the cellular increase in both CE and TG by greater than 90%. | Orlistat | lipoprotein lipase | Homo sapiens |
2 | Addition of tetrahydrolipstatin (THL, an LPL active-site inhibitor) to HTG-VLDL + LPL, inhibited the cellular increase in both CE and TG by greater than 90%. | Orlistat | lipoprotein lipase | Homo sapiens |
3 | Addition of tetrahydrolipstatin (THL, an LPL active-site inhibitor) to HTG-VLDL + LPL, inhibited the cellular increase in both CE and TG by greater than 90%. | Orlistat | lipoprotein lipase | Homo sapiens |
4 | Addition of tetrahydrolipstatin (THL, an LPL active-site inhibitor) to HTG-VLDL + LPL, inhibited the cellular increase in both CE and TG by greater than 90%. | Orlistat | lipoprotein lipase | Homo sapiens |